ADDICTION TREATMENT MARKET ANALYSIS

Addiction Treatment Market, By Type (Alcohol Addiction, Tobacco/Nicotine Addiction, Opioid Addiction, and Others), By Drug Type (Opioids (Buprenorphine, Methadone, Naltrexone), Nicotine Replacement Therapies (Nicotine Gums, Nicotine Patches, Nicotine Lozenges, Non-Nicotine Medication, Varenicline, and Bupropion), By Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

On May 14, 2024, Lifespan Health System, announced that they had launched a new addiction treatment program that seeks to offer same-day help. The program is called Addiction Care Today, and it hopes to offer walk-in and same-day appointments for people seeking to begin treatment for substance use disorders.
On February 9, 2024, Union Council of Ministers, announced that they had launched 41 addiction treatment facilities in Delhi for drug addicts. The facilities will provide free treatment, counselling and free medicines to people struggling with substance addiction problems
In May 2023, Camurus AB, a Swedish science-led biopharmaceutical company, announced that the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD).